Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
Dysfunction of the lymphatic system leads to secondary lymphedema and results in degradation of quality of life. Here, the authors show that delivery of nucleoside-modified Vascular Endothelial Growth Factor C (VEGFC) mRNA, encapsulated in lipid nanoparticles, induces organ-specific lymphatic growth...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e53077cda0b04c41bea9adf1cf679075 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e53077cda0b04c41bea9adf1cf679075 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e53077cda0b04c41bea9adf1cf6790752021-12-02T18:06:25ZNucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema10.1038/s41467-021-23546-62041-1723https://doaj.org/article/e53077cda0b04c41bea9adf1cf6790752021-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23546-6https://doaj.org/toc/2041-1723Dysfunction of the lymphatic system leads to secondary lymphedema and results in degradation of quality of life. Here, the authors show that delivery of nucleoside-modified Vascular Endothelial Growth Factor C (VEGFC) mRNA, encapsulated in lipid nanoparticles, induces organ-specific lymphatic growth and reverses experimental lymphedema.Dániel SzőkeGábor KovácsÉva KemecseiLászló BálintKitti Szoták-AjtayPetra AradiAndrea Styevkóné DinnyésBarbara L. MuiYing K. TamThomas D. MaddenKatalin KarikóRaghu P. KataruMichael J. HopeDrew WeissmanBabak J. MehraraNorbert PardiZoltán JakusNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-18 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Dániel Szőke Gábor Kovács Éva Kemecsei László Bálint Kitti Szoták-Ajtay Petra Aradi Andrea Styevkóné Dinnyés Barbara L. Mui Ying K. Tam Thomas D. Madden Katalin Karikó Raghu P. Kataru Michael J. Hope Drew Weissman Babak J. Mehrara Norbert Pardi Zoltán Jakus Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema |
description |
Dysfunction of the lymphatic system leads to secondary lymphedema and results in degradation of quality of life. Here, the authors show that delivery of nucleoside-modified Vascular Endothelial Growth Factor C (VEGFC) mRNA, encapsulated in lipid nanoparticles, induces organ-specific lymphatic growth and reverses experimental lymphedema. |
format |
article |
author |
Dániel Szőke Gábor Kovács Éva Kemecsei László Bálint Kitti Szoták-Ajtay Petra Aradi Andrea Styevkóné Dinnyés Barbara L. Mui Ying K. Tam Thomas D. Madden Katalin Karikó Raghu P. Kataru Michael J. Hope Drew Weissman Babak J. Mehrara Norbert Pardi Zoltán Jakus |
author_facet |
Dániel Szőke Gábor Kovács Éva Kemecsei László Bálint Kitti Szoták-Ajtay Petra Aradi Andrea Styevkóné Dinnyés Barbara L. Mui Ying K. Tam Thomas D. Madden Katalin Karikó Raghu P. Kataru Michael J. Hope Drew Weissman Babak J. Mehrara Norbert Pardi Zoltán Jakus |
author_sort |
Dániel Szőke |
title |
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema |
title_short |
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema |
title_full |
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema |
title_fullStr |
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema |
title_full_unstemmed |
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema |
title_sort |
nucleoside-modified vegfc mrna induces organ-specific lymphatic growth and reverses experimental lymphedema |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/e53077cda0b04c41bea9adf1cf679075 |
work_keys_str_mv |
AT danielszoke nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT gaborkovacs nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT evakemecsei nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT laszlobalint nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT kittiszotakajtay nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT petraaradi nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT andreastyevkonedinnyes nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT barbaralmui nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT yingktam nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT thomasdmadden nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT katalinkariko nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT raghupkataru nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT michaeljhope nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT drewweissman nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT babakjmehrara nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT norbertpardi nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema AT zoltanjakus nucleosidemodifiedvegfcmrnainducesorganspecificlymphaticgrowthandreversesexperimentallymphedema |
_version_ |
1718378664182153216 |